Stockreport

Milestone Pharmaceuticals: Selling The News On Cardamyst Approval Makes No Sense [Seeking Alpha]

Milestone Pharmaceuticals Inc. - Common Shares  (MIST) 
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am Check Earnings Report
PDF MIST's Cardamyst demonstrated rapid efficacy, favorable safety, and potential to reduce costly emergency visits, supporting robust market adoption. With over $150 mil [Read more]